Apotex Raises C$1.3 Billion in Toronto IPO at C$24, Canada's Biggest Since 2021
Updated
Updated · Bloomberg · Jun 10
Apotex Raises C$1.3 Billion in Toronto IPO at C$24, Canada's Biggest Since 2021
3 articles · Updated · Bloomberg · Jun 10
Summary
C$1.3 billion was raised by Apotex Health Corp. and selling shareholders after the Toronto IPO priced at C$24 a share, the top of the marketed range.
35.4 million new shares were sold by Apotex and about 18.8 million by existing holders, after the company increased the size of the offering on Monday.
The pricing confirmed earlier expectations that strong demand would support the high end of the C$20-to-C$24 range.
Canada's generic drug maker delivered the country's largest IPO since 2021, giving the Toronto market a rare blockbuster listing.